Navigation Links
Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope
Date:7/29/2013

months, outperforming the S&P 500, which has gained 6.91% during the same period. Register today and access free research on GERN at:

http://www.AAAResearchReports.com/GERN072913.pdf

Shares of Incyte Corporation edged lower on Friday, reversing some of their recent gains. The company's shares oscillated between $22.74 and $23.46 before finishing the session 0.17% lower at $23.34. A total of 553,069 shares were traded, which is below the daily average volume of 1.18 million. Incyte's shares have gained 2.14% in the last three trading sessions and 6.09% in the last one month, outperforming the S&P 500 during the respective periods. Moreover, the stock is currently trading above its 50-day and 200-day moving averages. The free report on INCY can be downloaded by signing up now at:

http://www.AAAResearchReports.com/INCY072913.pdf

Spectrum Pharmaceuticals, Inc.'s stock fluctuated between gains and losses on Friday before finishing the day flat. The company's shares oscillated between $8.26 and $8.50 before closing the day flat at $8.39. A total of 439,651 shares were traded, which is below the daily average volume of 917,988. Spectrum Pharmaceuticals' shares fell by 1.76% last week. In the last one month, however, the stock has outperformed the broader market, gaining 12.47% as compared to an advance of 5.31% in the S&P 500. A free report on SPPI can be accessed by registering at:

http://www.AAAResearchReports.com/SPPI072913.pdf

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mi
    '/>"/>

SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
2. Todays Research on Incyte and Arena Pharma: Biotech Stocks Up on Drug Approvals
3. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
4. Todays Technical View: AstraZeneca, GlaxoSmithKline, Keryx Biopharma, and Raptor Pharma
5. Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma
6. MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCalls Microscope
7. Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCalls Microscope
8. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
9. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
10. Enox Biopharma, Inc. Grants TTA LTD License To Wound Care Applications
11. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched Sound ... Patients listen to sound therapy that is tailor-made for ... to months, their tinnitus volume decreases. , AudioNotch has previously ... Notched White Noise. Now, AudioNotch is pleased to announce to ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 Date: ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, Warrington, ... only national nonprofit organization solely dedicated to finding a cure ... those affected worldwide, will host its annual Crystal Ball on ...
(Date:1/14/2014)... January 14, 2014 Histogen, Inc., a ... of cells grown under simulated embryonic conditions, today announced ... with Suneva Medical, Inc. for physician-dispensed aesthetic products containing ... , This agreement is an amendment to the existing ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... ... the FBRM® C35 particle size distribution technology in the particle characterization and material sciences ... 26-29 in Nuremberg, Germany. , ... (PRWEB) May 18, 2010 -- The Powtech/TechnoPharm jury awarded METTLER TOLEDO the ...
... Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading ... today announced that it reached an agreement to sell its RapidTrace ® ... Biotage AB for $16.5 million in cash.   , ... "Divesting these product lines is a ...
... (Nasdaq: SIAL ) will be presenting at the Baird,s 2010 Growth Stock ... ( 2:15 PM EDT ) in Chicago, IL.  Interested parties may ...  Users can click the "Webcast" icon to access this file.   , ... About Sigma-Aldrich: Sigma- Aldrich ...
Cached Biology Technology:FBRM C35 In-Process Particle Characterization Technology Receives Powtech/TechnoPharm Innovation Award 2010 2FBRM C35 In-Process Particle Characterization Technology Receives Powtech/TechnoPharm Innovation Award 2010 3Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage 2Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage 3Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage 4Sigma-Aldrich Corporation to Present at the Baird's 2010 Growth Stock Conference on Thursday, May 20, 2010 2
(Date:4/24/2014)... decade-long effort by members of the International Glossina Genome ... of the tsetse fly, Glossina morsitans . The ... a potentially deadly disease endemic in sub-Saharan Africa. The ... new ways to prevent the disease and provide insights ... fly is quite unique in the insect world: it ...
(Date:4/24/2014)... New Rochelle, NY, April 24, 2014D-ribose is a ... nutritional supplement, and as a starting compound for ... of Escherichia coli to increase the ... step toward achieving more efficient industrial-scale production of ... in Industrial Biotechnology , a peer-reviewed journal ...
(Date:4/24/2014)... have identified the structural features that enable the ... endogenous RNAs in living cells. , When viruses ... and hijack cellular resources for the production of ... RNA molecules that are delivered directly to (in ... in the host cell, and provide the blueprints ...
Breaking Biology News(10 mins):Genetic code of the deadly tsetse fly unraveled 2Viral infections: Identifying the tell-tale patterns 2Viral infections: Identifying the tell-tale patterns 3
... have discovered that mimecan and Thioredoxin Domain-Containing Protein ... The research article describing this work entitled Differential ... in Colorectal Adenoma and Cancer: A Proteomic Study ... of Experimental Biology and Medicine., Adenoma is the ...
... other fish in the rivers of Californias Central Valley ... researchers at Duke University and the National Oceanic and ... may serve as a cautionary tale to policymakers, scientists ... the construction of new dams in the region. ...
... of males than females are born worldwide every year. In ... than girls, there has been an apparent decline in the ... including Canada, Denmark, England, Germany, Japan and the United States. ... that can influence the probability of giving birth to a ...
Cached Biology News:A search for biomarkers for early detection of colorectal cancer 2New paper examines dams' effects on California salmon 2Weight gain between first and second pregnancies associated with increased odds of male second child 2